Chronic skin inflammatory diseases including psoriasis and atopic dermatitis affect millions worldwide, imposing substantial physical, psychological, and economic burdens. Despite advances in topical therapies, conventional formulations suffer from poor skin penetration, rapid clearance, local and systemic side effects, and suboptimal patient adherence. Polymeric nanogels, internally crosslinked three-dimensional polymer networks with dimensions of 10–200 nm, emerged as promising platforms to overcome these limitations. Their unique properties including high water content, tunable porosity, biocompatibility, deformability, and stimulus-responsive behavior enhance skin penetration allowing for targeted therapeutic action. This review examines nanogel synthesis methods optimized for targeting skin inflammatory diseases, including biopolymer-based approaches utilizing chitosan and hyaluronic acid, offering insights into how different methods and advanced architecture provide multifunctional capacities and bioactivities. Translation challenges including manufacturing scalability, long-term safety assessment, and regulatory compliance are critically discussed alongside emerging opportunities in personalized medicine and smart microneedle integrated systems for adaptive therapy.
Silva et al. (Thu,) studied this question.